Menu
GeneBe

chr19-18450550-G-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_006532.4(ELL):ā€‹c.1392C>Gā€‹(p.Asp464Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000288 in 1,613,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00012 ( 0 hom., cov: 33)
Exomes š‘“: 0.00031 ( 0 hom. )

Consequence

ELL
NM_006532.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.169
Variant links:
Genes affected
ELL (HGNC:23114): (elongation factor for RNA polymerase II) Enables phosphatase binding activity. Involved in positive regulation of transcription, DNA-templated and snRNA transcription. Located in cytosol; nuclear body; and transcriptionally active chromatin. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.032938153).
BS2
High AC in GnomAd4 at 18 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ELLNM_006532.4 linkuse as main transcriptc.1392C>G p.Asp464Glu missense_variant 8/12 ENST00000262809.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ELLENST00000262809.9 linkuse as main transcriptc.1392C>G p.Asp464Glu missense_variant 8/121 NM_006532.4 P1
ELLENST00000596124.3 linkuse as main transcriptc.993C>G p.Asp331Glu missense_variant 8/121
ELLENST00000594635.6 linkuse as main transcriptc.*1227C>G 3_prime_UTR_variant, NMD_transcript_variant 9/131
ELLENST00000608165.1 linkuse as main transcript upstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.000118
AC:
18
AN:
152164
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000162
AC:
40
AN:
247076
Hom.:
0
AF XY:
0.000179
AC XY:
24
AN XY:
134382
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000262
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000305
AC:
446
AN:
1460880
Hom.:
0
Cov.:
32
AF XY:
0.000288
AC XY:
209
AN XY:
726772
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000380
Gnomad4 NFE exome
AF:
0.000383
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.000118
AC:
18
AN:
152164
Hom.:
0
Cov.:
33
AF XY:
0.0000942
AC XY:
7
AN XY:
74324
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000221
Gnomad4 OTH
AF:
0.000956
Alfa
AF:
0.000201
Hom.:
0
Bravo
AF:
0.000121
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000215
AC:
26
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 12, 2023The c.1392C>G (p.D464E) alteration is located in exon 8 (coding exon 8) of the ELL gene. This alteration results from a C to G substitution at nucleotide position 1392, causing the aspartic acid (D) at amino acid position 464 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
4.3
DANN
Benign
0.20
DEOGEN2
Benign
0.038
T;T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.73
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.46
T;T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.033
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.55
N;.
MutationTaster
Benign
0.97
N
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.0
N;.
REVEL
Benign
0.021
Sift
Benign
0.91
T;.
Sift4G
Benign
0.79
T;T
Polyphen
0.0
B;.
Vest4
0.13
MutPred
0.34
Loss of MoRF binding (P = 0.112);.;
MVP
0.24
MPC
0.018
ClinPred
0.011
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.038
gMVP
0.079

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs370344034; hg19: chr19-18561360; API